Advertisements

Баклосан

Quick links to important sections

Баклосан

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Баклосан

The following section defines the drug Баклосан (Baclofen), detailing its core components and general purpose as a foundational medical entity, strictly excluding usage instructions, specific indications, and safety information.

Property Description
Active ingredient Baclofen
Form Tablets (Oral), Solution (Oral/Intrathecal)
Pharmacological class Skeletal Muscle Relaxant, GABAB Receptor Agonist
General purpose Reducing severe muscle spasms and stiffness
Origin Synthetic Derivative of gamma-Aminobutyric acid (GABA)

What Type of Medicine is Баклосан (Baclofen)?

Баклосан is a pharmaceutical preparation widely recognized as a skeletal muscle relaxant and a specific antispastic agent. Its active ingredient is the substance Baclofen, which is structurally a synthetic derivative of gamma-Aminobutyric acid (GABA). This agent is classified as a Central Nervous System (CNS) depressant and specifically functions as a GABAB Receptor Agonist. Pharmacological studies confirm that its action primarily targets pathological hyperactivity stemming from CNS disorders, a mechanism that distinguishes it from peripheral muscle relaxants.

Composition and Available Preparations

Baclofen is an International Nonproprietary Name (INN) substance, manufactured as a single-active-ingredient product across various brands, including Баклосан. The medicine is commonly available via the oral route in tablets and sometimes as an oral solution or granules. A differentiating and specialized feature is the availability of an Intrathecal Solution, which permits direct delivery to the spinal cord nerves for severe cases. This targeted delivery option is clinically recognized for maximizing therapeutic action at the site of spasticity.

What is the General Purpose of Antispastic Agents?

The general purpose of antispastic agents like Баклосан is to reduce the severity of involuntary muscle tightness and hyperactivity. By acting on the spinal cord nerves, Baclofen works to quiet the overactive reflex signals that trigger persistent spasms and excessive muscle stiffness. This effect provides fundamental relief from the constant, pathological tension that results from various conditions affecting the CNS.

Regulatory References

  1. Baclofen: MedlinePlus Drug Information
Advertisements

What side effects are possible with Баклосан?

Possible side effects and safety information

The safety profile of Baclofen (Баклосан) is based on official regulatory documentation, primarily classified by the frequency and organ system affected. The most frequently reported adverse reactions are related to its central nervous system (CNS) depressant activity.


Official Adverse Reactions and Frequency

Side effects are categorized by frequency, as established in regulatory documents such as the Summary of Product Characteristics (SmPC):

Classification Examples of Reactions
Very Common Drowsiness, Sedation
Common Fatigue, Dizziness, Headache, Nausea, Muscle Weakness, Hypotension, Respiratory Depression

These effects, particularly drowsiness and muscle weakness, are more likely to appear at the beginning of treatment or during dose escalation, a pattern explicitly noted in regulatory safety data. Other reactions, classified as Uncommon or Rare, involve psychiatric, visual, and gastrointestinal disturbances.


Serious Adverse Reactions and Safety Constraints

Official labeling documents specific serious adverse reactions that require clinical attention. These include Respiratory Depression and a potentially severe Withdrawal Syndrome, which may involve seizures and rhabdomyolysis if the medication is stopped abruptly.

Safety considerations are also noted for specific populations. Older adults may be more susceptible to adverse effects, especially confusion and drowsiness, while patients with Renal Impairment face an increased risk of toxicity due to drug accumulation. The medication is contraindicated in cases of known hypersensitivity and requires caution in conditions like Epilepsy, due to the risk of worsening seizure control.

Advertisements

Overdose and Emergency Response

Overdose with Baclofen (Баклосан) constitutes a medical emergency defined by severe Central Nervous System depression and cardiorespiratory effects. The officially documented clinical manifestations progress rapidly from drowsiness, confusion, and dizziness to deep coma and potential loss of consciousness. Critical outcomes documented in regulatory sources include respiratory failure, generalized seizures, marked muscular hypotonia (flaccidity), and severe systemic effects such as hypotension (low blood pressure) and bradycardia (slow heart rate).

Immediate medical attention and hospitalization are explicitly mandated by regulatory guidance for any suspected overdose due to the potential for life-threatening cardiovascular collapse and respiratory depression. Patients with impaired renal function are noted to face an increased risk of toxicity due to the drug's reduced clearance.

The official management principle is strictly symptomatic and supportive, as regulatory documents state that no specific antidote is known. Supportive care involves measures such as securing the airway, providing assisted ventilation for respiratory failure, and managing low blood pressure with intravenous fluids. Due to the potential for effects to persist for several days, intensive monitoring of vital signs and hospital observation are required.

Advertisements

Therapeutic Uses of Баклосан

What Баклосан Treats: Main Uses and Benefits

This medication is commonly used to relieve muscle spasms (painful, involuntary tightening) and spasticity (chronic, excessive muscle stiffness), which are symptoms of increased neurological or muscular activity. The therapeutic domain for Baclofen (Баклосан) includes managing spasticity associated with conditions like Multiple Sclerosis (MS), Spinal Cord Injuries, and other spinal lesions.

The medication offers supportive relief for these intense manifestations, helping patients cope more steadily with the physical distress associated with their condition. It is generally applied in clinical settings when symptoms become intense or disruptive, and additional symptomatic management is needed. The key therapeutic benefit contributes to improved day-to-day comfort and movement.

Quick Fact: Relief for Spasticity and Painful Spasms

By easing the overall symptom load, the treatment may assist with maintaining functional stability and supports improved daily living during symptomatic periods. The supportive care approach helps address symptoms related to physical discomfort and symptoms that create noticeable physiological strain.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Баклосан (Baclofen) — Official Regulatory Information

Baclofen is generally permitted for use in adults and children of certain ages/weights, but its use is restricted or prohibited in specific patient groups based on formal regulatory documentation.

Contraindications and Restrictions

Classification Population/Condition
Contraindicated Patients with known hypersensitivity (allergy) to baclofen or any of the product's excipients.
Use Restricted Patients with kidney (renal) impairment require lower doses and close monitoring, with use generally avoided in end-stage renal disease unless the benefit outweighs the risk.
Requires Caution Use demands careful supervision in patients with a history of epilepsy (seizures), peptic ulcers, cerebrovascular diseases (e.g., stroke), hepatic impairment, or certain psychiatric disorders (e.g., schizophrenia, confusional states), as these conditions may be exacerbated.
Age/Weight Rules Oral formulations are typically not suitable for use in children with a body weight below 33 kg. Safety and efficacy for the oral form have not been established in children under 12 years by some regulators, but other formulations are approved for patients as young as one month or four years, depending on the route.
Pregnancy/Lactation In pregnancy, the drug should be administered only if the potential benefit justifies the potential risk to the fetus (typically Category C). Low levels pass into breast milk, and the newborn should be monitored for signs of sedation.

Note: A cautious dosage schedule and close surveillance are generally recommended for the elderly and patients with spasticity of cerebral origin, as they are more likely to experience adverse effects.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Baclofen (Баклосан) details specific drug–drug and drug–substance interaction patterns, primarily tied to central nervous system (CNS) effects and the drug's elimination route.

Co-administration with Alcohol and Other CNS Depressants (including opioids, sedatives, and antihistamines) is documented to result in an additive CNS depressant effect. This pharmacodynamic interaction increases the risk of profound sedation, respiratory depression, and hypotension.

Pharmacodynamic and Pharmacokinetic Interactions

Interaction Entity Official Outcome Statement
Tricyclic Antidepressants (TCAs) Co-administration may potentiate the effects, resulting in pronounced muscular hypotonia (severe muscle weakness).
Antihypertensive Agents May lead to an additive hypotensive effect (lowering of blood pressure).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) May reduce the excretion rate of Baclofen, potentially resulting in higher serum levels and increased toxicity risk.
High-Fat Meal (Oral Suspension) Results in a measured reduction in peak plasma concentration (Cmax) and overall exposure (AUC) of the oral suspension.

Population-Specific Interaction Notes

The interaction profile is amplified for patients with Renal Impairment. Since Baclofen is predominantly cleared unchanged by the kidneys, impaired renal function increases the risk of drug accumulation and severe neurotoxicity. There are no mandatory timing-separation rules documented between Baclofen and other medicinal products.

Advertisements

Mechanism of Action

GABA B Receptor Activation

This section details the drug's primary biological target: binding to the GABA B receptor in the central nervous system, resulting in increased inhibitory signaling. .

The drug functions as a selective agonist for the GABA B receptor, mimicking the action of the body's natural inhibitory neurotransmitter. This molecular interaction activates an intracellular signaling cascade within the nerve cell, which results in reduced nerve excitability and decreased release of excitatory neurotransmitters.


Modulation of Spinal Reflex Arcs

This section explains how the drug's action in the central nervous system affects nerve circuits and influences downstream motor neuron activity.

The primary physiological effect occurs in the spinal cord, where the enhanced inhibition reduces the activity of reflex arcs exhibiting heightened response. By interrupting the signaling loops between nerves, the drug limits the transmission of excitatory impulses to the motor neurons. This mechanism affects the control mechanisms governing muscle tone and results in reduced motor nerve output to skeletal muscle.

Advertisements

Dosage and Administration Information

Baclofen (marketed as Баклосан in some regions) is an oral medication that should be taken exactly as prescribed by your healthcare provider. The dosage is individualized based on the patient's clinical response and tolerability, and treatment should always begin with a low dose that is gradually increased.

Administration and Dosing

  • Oral Tablets: Baclofen tablets are generally taken by mouth three times daily at evenly spaced intervals, often with food or milk to help avoid stomach upset. Do not chew or crush tablets unless specifically instructed by your physician.
  • Initial Adult Dosage: For the alleviation of signs and symptoms of spasticity, the typical starting dose for adults and children 12 years and older is 5 mg three times daily for three days. Your doctor will then gradually increase the dose, usually by 5 mg every three days, until an optimal therapeutic response is achieved.
  • Maximum Dose: The recommended maximum daily dose for oral baclofen is 80 mg, administered in divided doses.
Dosing Regimen (Suggested) Dosage Frequency
Days 1–3 5 mg 3 times daily
Days 4–6 10 mg 3 times daily
Days 7–9 15 mg 3 times daily
Days 10–12 20 mg 3 times daily

Important Safety Information

  • Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue your regular dosing schedule. Do not take a double dose to make up for a missed dose.
  • Do Not Stop Abruptly: It is crucial not to stop taking Baclofen suddenly. Abrupt discontinuation, regardless of the cause, can lead to severe adverse reactions, including hallucinations, high fever, seizures, and exaggerated rebound spasticity. Your doctor will provide instructions for gradually reducing your dose before stopping the medication entirely to prevent withdrawal symptoms.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Баклосан (Baclofen)

The body of research that has studied Baclofen for muscle stiffness and spasms includes primarily Randomized Controlled Trials (RCTs), where patients are randomly assigned to receive either the medicine or a comparison treatment (like a placebo), and from systematic reviews that combine results from multiple trials. This research framework is used in research exploring how symptoms change over time and helps scientists understand group patterns, not personal outcomes.


Evidence for Managing Spasticity Associated with Multiple Sclerosis (MS)

Researchers conducted short-term RCTs to evaluate the oral form of Baclofen in adult patients diagnosed with Multiple Sclerosis (MS) who experienced spasticity. Studies monitored patient-reported outcomes describing perceived discomfort and aspects of daily-life functioning. The main outcomes measured included changes in muscle tone, typically assessed using objective tools like the Ashworth Scale, and the frequency of painful muscle spasms, measured by scales such as the Penn Spasm Score.

Systematic reviews report that trials described patterns related to the measurement of muscle tone scores in patients receiving Baclofen compared to those receiving a placebo or an alternate treatment. Long-term evidence has been collected primarily through observational cohort studies, particularly for the intrathecal (spinal fluid) method of delivery. What remains uncertain is the full characterization of long-term functional outcomes, such as how well patients can perform daily activities over many years.


Evidence for Spasticity Following Spinal Cord Injury (SCI) and Spinal Lesions

Research on spasticity linked to Spinal Cord Injury (SCI) includes RCTs that evaluated the oral medicine against a placebo, as well as specific crossover trials for the highly concentrated intrathecal treatment. The research examined changes in muscle tone using the Ashworth Scale, spasm frequency, and overall reflex activity. Trials exploring short-term symptom changes reported that researchers measured differences in the Ashworth Scale measurements and spasm frequency in the groups receiving the medicine.

There is limited quantitative functional data derived from rigorous, randomized, long-term trials. While research highlights what is known about muscle tone, there is limited information on the direct, long-term impact on measures like Activities of Daily Living (ADLs). Additionally, consistency of outcomes across the wide range of different types and severities of spinal lesions is an area where evidence quality varies across studies.

Key Studies & References

  1. Label: BACLOFEN tablet - DailyMed (FDA Labeling)
  2. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen - Journal of Rehabilitation Medicine (Systematic Review)
  3. Intrathecal baclofen for severe spasticity: a meta-analysis - NCBI (Critical Abstract/Systematic Review)
  4. Spasticity in under 19s: management - NICE Guideline CG145
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Баклосан (FAQ)


Q: Is Баклосан the same as Baclofen?

Yes. According to official drug information, Baclofen is the active ingredient and the official International Nonproprietary Name (INN) for this medicine. Баклосан is a brand name or regional trade name used for the product that contains Baclofen.


Q: What specific conditions does Баклосан typically treat besides muscle spasticity?

The FDA-approved indication for the oral medication is specifically for the management of spasticity resulting from conditions such as Multiple Sclerosis and Spinal Cord Injuries/Diseases. The official labeling explicitly states the drug is not indicated for spasms caused by rheumatic disorders.


Q: How long does it typically take for Баклосан to start working after taking a dose?

Official information for the oral tablet doesn't typically specify an exact onset time. However, clinical study data for the specialized intrathecal formulation suggests the onset of action is typically within thirty minutes to one hour after administration.


Q: When can a patient expect to feel the full therapeutic effect of Баклосан?

The full therapeutic effect is typically reached through a period of dose titration. This involves a healthcare provider determining the patient’s optimal dose based on response and tolerability, rather than being felt immediately after the first dose.


Q: Are there any long-term side effects associated with continuous use of Баклосан?

Official regulatory information focuses primarily on common initial side effects and the critical risk of withdrawal syndrome if the medication is abruptly discontinued after prolonged use. Specific long-term consequences beyond this are not always detailed in standard initial labeling.


Q: Can Баклосан affect your sleep or cause nightmares?

Yes, regulatory documents list central nervous system effects such as drowsiness and insomnia (difficulty sleeping) as common side effects. Nightmares are listed in some product information as an uncommon side effect.


Q: Can Баклосан impact a person's mood or cause confusion?

Official safety information notes that confusion is a reported side effect, especially in older adults. Furthermore, the labeling advises caution for individuals with a history of certain psychiatric disorders, as the drug may potentially precipitate or exacerbate psychotic symptoms or confusional states.


Q: What is the difference between oral Баклосан and the intrathecal pump version?

The oral tablet is taken by mouth, but the intrathecal solution is a specialized, highly concentrated form delivered directly into the spinal fluid using a programmable pump. This direct delivery allows for effective concentrations at the spinal cord with significantly lower systemic levels, which may potentially reduce some overall side effects.


Q: Does the body build up a tolerance to the effects of Баклосан over time?

Tolerance, which requires increased dosing, has been noted with the specialized intrathecal formulation. Regulatory information for the oral form does not widely address the development of tolerance to the primary therapeutic effect.


Q: How is Баклосан eliminated from the body?

According to the clinical pharmacology data, Baclofen is primarily eliminated from the body unchanged by the kidneys. This renal elimination is the reason why patients with impaired kidney function face an increased risk of drug accumulation.


Q: Are there specific symptoms that indicate too much Баклосан has been taken (overdose)?

Symptoms listed in the official overdosage section include profound central nervous system depression, which can progress to coma, severe muscular weakness (hypotonia), and respiratory depression. Other effects like seizures may also occur.


Q: Why is it important to tell your doctor about any history of mental health conditions before starting Баклосан?

Caution is required because the official labeling warns that Baclofen may precipitate or exacerbate psychotic symptoms in patients with a history of certain psychiatric disorders or schizophrenia. This risk exists both during therapy and following abrupt withdrawal.


Q: Does Баклосан help with the pain that accompanies muscle spasms?

Official indications state that the medication is used for the relief of spasticity and its accompanying symptoms, which may include concomitant pain, clonus, and muscular rigidity.


Q: Can Баклосан be used for muscle spasms caused by rheumatic disorders?

No. The official limitations of use explicitly state that the drug is not indicated for the treatment of skeletal muscle spasms that are a result of rheumatic disorders.


Q: Does constipation or nausea commonly occur with Баклосан use?

Official adverse reaction lists commonly include nausea as a reported side effect. While not always listed among the most common effects, constipation is a known and reported gastrointestinal side effect.


Q: What is the connection between Баклосан and the GABA-B receptors?

Baclofen is an analog of the inhibitory neurotransmitter GABA. Official information states that it acts as a selective agonist for the GABA B receptor subtype in the central nervous system, which is the biological target for its muscle-relaxing effects.


Q: Are there different forms of Баклосан (tablets, liquid, etc.)?

Yes, according to the official product information, the medication is available in several forms. These commonly include standard oral tablets, an oral suspension or solution, and a specialized intrathecal injection for direct spinal administration.


Q: How often is Баклосан usually prescribed to be taken per day?

Official product information states that the typical adult regimen involves taking the medication in divided doses daily. Specific frequency and timing instructions are individualized and provided by a healthcare professional.


Q: Is there a risk of dependence or misuse with Баклосан?

Although the drug is not generally classified as a controlled substance, the requirement for a gradual dose reduction to prevent severe withdrawal symptoms indicates a potential for physical dependence with long-term use.


Q: Is it common to experience headaches after starting Баклосан?

Yes, official safety documentation lists headache as a Common adverse reaction. This side effect is often more noticeable when starting treatment or during dose changes.


Q: Can Баклосан cause urinary retention or increased frequency of urination?

Official documentation reports that the medication can cause adverse effects on the genitourinary system. These effects may include an increase in urinary frequency and, less commonly, the inability to pass urine (urinary retention).


Q: What are 'flexor spasms' and how does Баклосан help them?

Flexor spasms are a type of involuntary muscle tightening that bends a limb. Regulatory documents explicitly state that the drug is indicated for the relief of spasticity symptoms like flexor spasms, clonus, and muscular rigidity, particularly those associated with Multiple Sclerosis.


Q: Are there any reported interactions between Баклосан and SSRI antidepressants?

Official drug interaction information suggests that using Baclofen with SSRI antidepressants may increase the risk of central nervous system depressant effects. This can lead to greater drowsiness, dizziness, and difficulty concentrating.


Q: Can people with Parkinson's disease safely use Баклосан?

Official product labeling explicitly states that the efficacy of the medication in Parkinson's disease has not been established. Due to this, the drug is typically not used for spasticity in this patient population.


Q: Does Баклосан help reduce muscle stiffness in cerebral palsy patients?

The efficacy of the oral form has not been fully established for spasticity related to cerebral palsy. However, the specialized intrathecal solution is officially indicated for managing severe spasticity of cerebral origin, which includes spasticity in cerebral palsy patients.


Q: What types of medications should not be taken with Баклосан?

Caution is advised against combining it with alcohol and other CNS depressants (like opioids and sedatives) due to a serious risk of increased sedation and respiratory depression. Interactions with certain antidepressants (TCAs) and NSAIDs are also noted in official warnings.


Q: Does taking Баклосан interact with diabetes medication or affect blood sugar levels?

Official adverse reaction reports have noted changes in blood sugar, including both high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia). Because of this, individuals with diabetes may need to have their blood sugar levels closely evaluated.

Advertisements

How should Баклосан be stored and disposed of?

Official Storage and Handling Requirements

Storage conditions for Baclofen (oral tablets) are defined as Controlled Room Temperature, which is 20 C to 25 C ( 68 F to 77 F), with permitted temperature excursions up to 30 C. The tablets must be stored in a well-closed container that is kept tightly closed and away from excess heat and moisture . Specific regulatory requirements also mandate protection from light and require that the container be equipped with a child-resistant closure.

Liquid Formulations and Stability

Certain Baclofen oral solutions require refrigeration at 2 C to 8 C, and must not be frozen . Stability constraints for some liquid forms mandate that any unused product must be discarded 2 months after first opening . All formulations must be kept out of the sight and reach of children .

Disposal of Unused Medicine

Unused or expired Baclofen should be disposed of by following authorized waste management procedures, such as using a drug take-back program or mail-back option. If these programs are unavailable, the medicine should be mixed with an undesirable substance, sealed in a bag, and thrown into the household trash, in accordance with local, regional, and national regulations .

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Баклосан found in:

A-Z Index: